(Q46013511)

English

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.

scientific article published on 14 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

B-S Cho

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

S Lee

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

Y-J Kim

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

N-G Chung

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

K-S Eom

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

H-J Kim

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

C-K Min

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

S-G Cho

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

D-W Kim

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

J-W Lee

10

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

W-S Min

11

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

C-C Kim

12

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

publication date

14 May 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

23

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

10

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

1763-1770

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

https://scigraph.springernature.com/pub.10.1038/leu.2009.102

0 references

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Allogeneic transplantation for ALL in adults

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B-lineage acute lymphoblastic leukaemia in first or second remission.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

21 January 2018

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic Stem Cell Transplantation in First Complete Remission Enhances Graft-versus-Leukemia Effect in Adults with Acute Lymphoblastic Leukemia: Antileukemic Activity of Chronic Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.102

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.102

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19440217

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46013511&oldid=1525897363"